This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, M.
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, M.
Right arrow Articles by Chen, J.

 Previous Article  |  Next Article 

Journal of Virology, December 2005, p. 15443-15451, Vol. 79, No. 24
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.24.15443-15451.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Activation of the ATR Pathway by Human Immunodeficiency Virus Type 1 Vpr Involves Its Direct Binding to Chromatin In Vivo

Maoyi Lai,1 Erik S. Zimmerman,2 Vicente Planelles,2 and Junjie Chen1*

Department of Molecular Pharmacology and Experimental Therapeutics, Division of Oncology Research, Mayo Clinic College of Medicine, Rochester, Minnesota,1 Division of Cellular Biology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah2

Received 20 April 2005/ Accepted 20 September 2005

The human immunodeficiency virus type 1 (HIV-1) protein Vpr (viral protein R) arrests cells in the G2 phase of the cell cycle, a process that requires activation of the ATR (ataxia-telangiectasia and Rad3-related) pathway. In this study we demonstrate that the expression of Vpr does not cause DNA double-strand breaks but rather induces ATR activation, as indicated by induction of Chk1 phosphorylation and the formation of {gamma}-H2AX and 53BP1 nuclear foci. We define a C-terminal domain containing repeated H(F/S)RIG sequences required for Vpr-induced activation of ATR. Further investigation of the mechanism by which Vpr activates the ATR pathway reveals an increase in chromatin binding of replication protein A (RPA) upon Vpr expression. Immunostaining shows that RPA localizes to nuclear foci in Vpr-expressing cells. Furthermore, we demonstrate direct binding of Vpr to chromatin in vivo, whereas Vpr C-terminal domain mutants lose this chromatin-binding activity. These data support a mechanism whereby HIV-1 Vpr induces ATR activation by targeting the host cell DNA and probably interfering with normal DNA replication.


* Corresponding author. Mailing address: Division of Oncology Research, Mayo Clinic, Guggenheim 1342, Rochester, MN 55905. Phone: (507) 538-1545. Fax: (507) 284-3906. E-mail: chen.junjie{at}mayo.edu.


Journal of Virology, December 2005, p. 15443-15451, Vol. 79, No. 24
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.24.15443-15451.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • McCall, C. M., Miliani de Marval, P. L., Chastain, P. D. II, Jackson, S. C., He, Y. J., Kotake, Y., Cook, J. G., Xiong, Y. (2008). Human Immunodeficiency Virus Type 1 Vpr-Binding Protein VprBP, a WD40 Protein Associated with the DDB1-CUL4 E3 Ubiquitin Ligase, Is Essential for DNA Replication and Embryonic Development. Mol. Cell. Biol. 28: 5621-5633 [Abstract] [Full Text]  
  • Huard, S., Elder, R. T., Liang, D., Li, G., Zhao, R. Y. (2008). Human Immunodeficiency Virus Type 1 Vpr Induces Cell Cycle G2 Arrest through Srk1/MK2-Mediated Phosphorylation of Cdc25. J. Virol. 82: 2904-2917 [Abstract] [Full Text]  
  • DeHart, J. L., Planelles, V. (2008). Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation. J. Virol. 82: 1066-1072 [Full Text]  
  • Maxwell, P. H., Curcio, M. J. (2007). Host Factors That Control Long Terminal Repeat Retrotransposons in Saccharomyces cerevisiae: Implications for Regulation of Mammalian Retroviruses. Eukaryot Cell 6: 1069-1080 [Full Text]  
  • Li, G., Elder, R. T., Qin, K., Park, H. U., Liang, D., Zhao, R. Y. (2007). Phosphatase Type 2A-dependent and -independent Pathways for ATR Phosphorylation of Chk1. J. Biol. Chem. 282: 7287-7298 [Abstract] [Full Text]  
  • Schrofelbauer, B., Hakata, Y., Landau, N. R. (2007). HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. USA 104: 4130-4135 [Abstract] [Full Text]  
  • Terada, Y., Yasuda, Y. (2006). Human Immunodeficiency Virus Type 1 Vpr Induces G2 Checkpoint Activation by Interacting with the Splicing Factor SAP145. Mol. Cell. Biol. 26: 8149-8158 [Abstract] [Full Text]  
  • Zimmerman, E. S., Sherman, M. P., Blackett, J. L., Neidleman, J. A., Kreis, C., Mundt, P., Williams, S. A., Warmerdam, M., Kahn, J., Hecht, F. M., Grant, R. M., de Noronha, C. M. C., Weyrich, A. S., Greene, W. C., Planelles, V. (2006). Human Immunodeficiency Virus Type 1 Vpr Induces DNA Replication Stress In Vitro and In Vivo. J. Virol. 80: 10407-10418 [Abstract] [Full Text]  
  • Ardon, O., Zimmerman, E. S., Andersen, J. L., DeHart, J. L., Blackett, J., Planelles, V. (2006). Induction of g2 arrest and binding to cyclophilin a are independent phenotypes of human immunodeficiency virus type 1 vpr.. J. Virol. 80: 3694-3700 [Abstract] [Full Text]